The store will not work correctly when cookies are disabled.
TILOMISOLE
ID: ALA2104737
Cas Number: 58433-11-7
PubChem CID: 42747
Max Phase: Phase
Molecular Formula: C17H11ClN2O2S
Molecular Weight: 342.81
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Synonyms: WY-18,251 | WY-18251 | TILOMISOLE|58433-11-7|Wy-18251|2-[1-(4-chlorophenyl)-[1,3]thiazolo[3,2-a]benzimidazol-2-yl]acetic acid|WY-18,251|Wy 18251|Tilomisol|3-(p-Chlorophenyl)thiazolo(3,2-a)benzimidazole-2-acetic acid|651G60U372|Tilomisolum|Thiazolo(3,2-a)benzimidazole-2-acetic acid, 3-(4-chlorophenyl)|Tilomisol [Spanish]|Tilomisolum [Latin]|Tilomisole [USAN:INN]|UNII-651G60U372|TILOMISOLE [INN]|Tilomisole (USAN/INN)|TILOMISOLE [USAN]|2-[1-(4-chlorophenyl)-[1,3]thiazolo[3,2-a]benzo[d]imidazol-2-ylShow More⌵
Canonical SMILES: O=C(O)Cc1sc2nc3ccccc3n2c1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C17H11ClN2O2S/c18-11-7-5-10(6-8-11)16-14(9-15(21)22)23-17-19-12-3-1-2-4-13(12)20(16)17/h1-8H,9H2,(H,21,22)
Standard InChI Key: PUYFLGQZLHVTHX-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-1.2875 2.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8875 1.0833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7667 2.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6625 2.3583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4167 1.0833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2875 3.1083 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.9125 0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9833 1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9292 2.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1292 0.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2000 2.5708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6167 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4000 0.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6792 0.8500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1542 -0.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4667 -2.9792 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.0875 -0.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2083 0.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2750 -1.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 -0.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 6 1 0
4 1 2 0
5 2 1 0
6 1 1 0
7 2 1 0
8 4 1 0
9 3 1 0
10 9 1 0
11 5 1 0
12 10 2 0
13 11 2 0
14 11 1 0
15 17 1 0
16 10 1 0
17 14 2 0
18 13 1 0
19 15 1 0
20 7 1 0
21 8 1 0
22 20 2 0
23 21 2 0
7 8 2 0
5 3 2 0
22 23 1 0
18 15 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.81 | Molecular Weight (Monoisotopic): 342.0230 | AlogP: 4.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.60 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.81 | CX Basic pKa: 3.86 | CX LogP: 3.74 | CX LogD: 1.48 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.60 | Np Likeness Score: -1.34 |
References
1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
2. Bell SC, Wei PH.. (1976) Syntheses of heterocylic fused thiazole acetic acids. 2., 19 (4): [PMID:1263204] [10.1021/jm00226a016] |
3. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |